Neovascular Age-Related Macular Degeneration

Ashburn, Va. – August 28, 2026 Quoin Pharmaceuticals announced positive interim results from the ongoing Phase 2/3 CL-QRX003-004 study...

Basel, Switzerland – August 28, 2026 Roche announced new two-year results from the Phase IIIb/IV SALWEEN study evaluating Vabysmo®...

ISELIN, N.J., July 24, 2026 Outlook Therapeutics has achieved a major regulatory milestone after the U.S. Food and Drug...